« Return to News | CROs/Service Providers

LabCorp to acquire Medtox Scientific

Tuesday, June 5, 2012 08:00 AM

Laboratory Corporation of America Holdings has inked a contract to acquire Medtox Scientific, a St. Paul, Minn.-based provider of high quality specialized laboratory testing services and on-site/point-of-collection testing (POCT) devices.

LabCorp Holdings will purchase Medtox for $27.00 per share in cash, representing a total enterprise value of approximately $241,000,000. The board of directors of Medtox unanimously approved the agreement and recommended approval of the transaction by Medtox 's shareholders.

"We are extremely pleased that Medtox, a premier forensic and clinical laboratory with a reputation for exceptional quality, dependability and customer service is joining our family," said David P. King, chairman and CEO of LabCorp. “This acquisition provides a strong foundation for growth in this business, as we build and expand LabCorp's toxicology center of excellence and add to the unrivaled assets of the LabCorp specialty testing group.”

Dick Braun, chairman and CEO of Medtox, said, "As part of LabCorp with its substantial resources and infrastructure, we expect to accelerate Medtox’s profitable growth and provide a stable and sustainable environment for our employees and clients."

The transaction is subject to customary closing conditions including the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and approval by Medtox's stockholders. The transaction is expected to close in the third quarter of 2012.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.